TY - JOUR
T1 - Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH)
T2 - A systematic analysis of expert opinion
AU - Lowe, F. C.
AU - Batista, J.
AU - Berges, R.
AU - Chartier-Kastler, E.
AU - Conti, G.
AU - Desgrandchamps, F.
AU - Dreikorn, K.
AU - O'Leary, M.
AU - Perez, M.
AU - Speakman, M.
AU - Trachtenberg, J.
AU - Tubaro, A.
AU - Meesen, B.
AU - Smets, L.
AU - Stoevelaar, H.
N1 - Funding Information:
This study was supported by an unrestricted educational grant from Boehringer Ingelheim GmbH.
PY - 2005/9
Y1 - 2005/9
N2 - Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.
AB - Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.
KW - Benign prostatic hyperplasia
KW - Disease progression
KW - Lower urinary tract symptoms
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=29944438602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=29944438602&partnerID=8YFLogxK
U2 - 10.1038/sj.pcan.4500806
DO - 10.1038/sj.pcan.4500806
M3 - Article
C2 - 15953934
AN - SCOPUS:29944438602
SN - 1365-7852
VL - 8
SP - 206
EP - 209
JO - Prostate Cancer and Prostatic Diseases
JF - Prostate Cancer and Prostatic Diseases
IS - 3
ER -
